Search research articles
Contact Us
Filters
Showing results (261-270 of 273) with videos related to
Page
of 28
Sort By:
Critical Care Medicine
|
May 8, 2026
Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP)
Madiha Hashmi, Rashan Haniffa, Deva Jayakumar, et al.
JAMA
|
October 25, 2023
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials
, Neill K J Adhikari, Madiha Hashmi, et al.
Nature Reviews. Microbiology
|
March 31, 2019
New filovirus disease classification and nomenclature
Jens H Kuhn, Takuya Adachi, Neill K J Adhikari, et al.
JAMA
|
October 4, 2021
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
, Lise J Estcourt, Alexis F Turgeon, et al.
Nature Communications
|
February 5, 2024
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Cathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Nature Communications
|
May 15, 2021
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Cathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Nature Communications
|
April 16, 2021
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Cathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
, , , et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
, , , et al.
The New England Journal of Medicine
|
June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia
, Todd C Lee, Lauren A Barina, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 273) with videos related to
Sort By:
Page
of 28
Critical Care Medicine
|
May 8, 2026
Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP)
Madiha Hashmi, Rashan Haniffa, Deva Jayakumar, et al.
JAMA
|
October 25, 2023
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials
, Neill K J Adhikari, Madiha Hashmi, et al.
Nature Reviews. Microbiology
|
March 31, 2019
New filovirus disease classification and nomenclature
Jens H Kuhn, Takuya Adachi, Neill K J Adhikari, et al.
JAMA
|
October 4, 2021
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
, Lise J Estcourt, Alexis F Turgeon, et al.
Nature Communications
|
February 5, 2024
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Cathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Nature Communications
|
May 15, 2021
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Cathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Nature Communications
|
April 16, 2021
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Cathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
, , , et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
, , , et al.
The New England Journal of Medicine
|
June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia
, Todd C Lee, Lauren A Barina, et al.
Page
of 28